1887

Abstract

Epstein–Barr virus is a human gammaherpesvirus that infects and establishes latency in B lymphocytes . The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. A panel of fusion proteins was constructed in which the fluorescent enhanced green fluorescent protein and DsRed protein domains were fused to the N- and C-termini of LMP2A and LMP2B. By fluorescence microscopy, LMP2B localized to perinuclear regions of both live and fixed transiently transfected cells. Co-localization was detected with markers for the endoplasmic reticulum and the trans-Golgi network. No evidence of co-localization of LMP2B with endosomes or surface expression was obtained. Transiently expressed LMP2B co-localized with transiently or constitutively expressed LMP2A. Confocal microscopy confirmed that LMP2A proteins localized to intracellular perinuclear compartments with markers for the trans-Golgi network. Only LMP2A proteins with C-terminal truncations were detected in the plasma membrane with extracellular loop1 epitope tags. These results indicate that the transmembrane domain of LMP2 proteins possess intracellular retention signals and suggest that LMP2A-mediated signalling effects are likely to be ectopic, originating from sites inside the cell close to the nucleus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-5-1025
2002-05-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/5/0831025a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-5-1025&mimeType=html&fmt=ahah

References

  1. Babcock G. J., Decker L. L., Volk M., Thorley-Lawson D. A. 1998; EBV persistence in memory B cells in vivo . Immunity 9:395–404
    [Google Scholar]
  2. Babcock G. J., Decker L. L., Freeman R. B., Thorley-Lawson D. A. 1999; Epstein–Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. Journal of Experimental Medicine 190:567–576
    [Google Scholar]
  3. Babcock G. J., Hochberg D., Thorley-Lawson D. A. 2000; The expression pattern of Epstein–Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13:497–506
    [Google Scholar]
  4. Cohen J. I. 1999; The biology of Epstein–Barr virus: lessons learned from the virus and the host. Current Opinion in Immunology 11:365–370
    [Google Scholar]
  5. Dawson C. W., George J. H., Blake S. M. S., Longnecker R., Young L. S. 2001; The Epstein–Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1. Virology 289:192–207
    [Google Scholar]
  6. Fruehling S., Lee S. K., Herrold R., Frech B., Laux G., Kremmer E., Grasser F. A., Longnecker R. 1996; Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobin signal transduction. Journal of Virology 70:6216–6226
    [Google Scholar]
  7. Khan G., Miyashita E. M., Yang B., Babcock G. J., Thorley-Lawson D. A. 1996; Is EBV persistence in vivo a model for B cell homeostasis?. Immunity 5:173–179
    [Google Scholar]
  8. Kieff E. 1996a; Epstein–Barr virus and its replication. In Fundamental Virology pp 1109–1162 Edited by Knipe D. M., Fields B. N., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  9. Kieff E. 1996b; Herpesviridae . In Fields Virology pp 2343–2396 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  10. Kim O. J., Yates J. L. 1993; Mutants of Epstein–Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture. Journal of Virology 67:7634–7640
    [Google Scholar]
  11. Konishi K. M., Maruo S., Kato H., Takada K. 2001; Role of Epstein–Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. Journal of General Virology 82:1451–1456
    [Google Scholar]
  12. Laux G., Perricaudet M., Farrell P. J. 1988; A spliced Epstein–Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO Journal 7:769–774
    [Google Scholar]
  13. Longnecker R. 2000; Epstein–Barr virus latency: LMP2, a regulator or means for Epstein–Barr virus persistence?. Advances in Cancer Research 79:175–200
    [Google Scholar]
  14. Longnecker R., Kieff E. 1990; A second Epstein–Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. Journal of Virology 64:2319–2326
    [Google Scholar]
  15. Longnecker R., Druker B., Roberts T. M., Kieff E. 1991; An Epstein–Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. Journal of Virology 65:3681–3692
    [Google Scholar]
  16. Longnecker R., Miller C. L., Miao X. Q., Marchini A., Kieff E. 1992; The only domain which distinguishes Epstein–Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro ; LMP2A is therefore nonessential. Journal of Virology 66:6461–6469
    [Google Scholar]
  17. Longnecker R., Miller C. L., Miao X. Q., Tomkinson B., Kieff E. 1993; The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein–Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro . Journal of Virology 67:2006–2013
    [Google Scholar]
  18. Miller G. 1990; The switch between latency and replication of Epstein–Barr virus. Journal of Infectious Diseases 161:833–844
    [Google Scholar]
  19. Miyashita E. M., Yang B., Lam K. M. C., Crawford D. H., Thorley-Lawson D. A. 1995; A novel form of Epstein–Barr virus latency in normal B cells in vivo. Cell 80593–601
    [Google Scholar]
  20. Miyashita E. M., Yang B., Babcock G. J., Thorley-Lawson D. A. 1997; Identification of the site of Epstein–Barr virus persistence in vivo as a resting B cell. Journal of Virology 71:4882–4891
    [Google Scholar]
  21. Qu L., Rowe D. T. 1992; Epstein–Barr virus latent gene expression in uncultured peripheral blood lymphocytes. Journal of Virology 66:3715–3724
    [Google Scholar]
  22. Rivailler P., Quink C., Wang F. 1999; Strong selective pressure for evolution of an Epstein–Barr virus LMP2B homologue in the rhesus lymphocryptovirus. Journal of Virology 73:8867–8872
    [Google Scholar]
  23. Rowe D. T. 1999; Epstein–Barr virus immortalization and latency. Frontiers in Bioscience 4:346–371
    [Google Scholar]
  24. Rowe D. T., Hall L., Joab I., Laux G. 1990; Identification of the Epstein–Barr virus terminal protein gene products in latently infected lymphocytes. Journal of Virology 64:2866–2875
    [Google Scholar]
  25. Sample J., Liebowitz D., Kieff E. 1989; Two related Epstein–Barr virus membrane proteins are encoded by separate genes. Journal of Virology 63:933–937
    [Google Scholar]
  26. Sugden B. 1994; Latent infection of B lymphocytes by Epstein–Barr virus. Seminars in Virology 5:197–205
    [Google Scholar]
  27. Thorley-Lawson D. A., Babcock G. J. 1999; A model for persistent infection with Epstein–Barr virus: the stealth virus of human B cells. Life Sciences 65:1433–1453
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-5-1025
Loading
/content/journal/jgv/10.1099/0022-1317-83-5-1025
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error